Legal status · United Kingdom
Is Semaglutide legal in the United Kingdom?
Yes. Semaglutide is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Semaglutide in the United Kingdom at a glance
| Classification | Licensed, prescription only (MHRA) |
|---|---|
| MHRA approval status | Approved by MHRA for its labeled use |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Semaglutide profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
MHRA has approved Semaglutide for at least one labeled indication, so a pharmaceutical-grade product exists in the United Kingdom and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Semaglutide is
A long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, with proven cardiovascular risk reduction.
Semaglutide is a once-weekly GLP-1 receptor agonist. It lowers blood glucose through glucose-dependent insulin secretion, slows gastric emptying, and reduces appetite through central and peripheral GLP-1 signaling.
Mechanism: Activates the GLP-1 receptor, increasing insulin secretion when glucose is elevated, suppressing glucagon, slowing gastric emptying, and acting on hypothalamic appetite centers to reduce food intake.
Regulatory history: FDA-approved (Ozempic, Rybelsus for T2D; Wegovy injection, Wegovy pill approved Dec 2025, and Wegovy HD 7.2 mg approved Mar 2026 for weight management)
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Semaglutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Semaglutide in other countries
Frequently asked questions
Is Semaglutide legal in the United Kingdom?
Yes. Semaglutide is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Semaglutide in the United Kingdom?
Only with a prescription. Semaglutide is classified as "Licensed, prescription only (MHRA)" in the United Kingdom, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Semaglutide MHRA approved?
Yes, for its labeled indication. In the United Kingdom Semaglutide is classified as "Licensed, prescription only (MHRA)". For comparison, the US FDA status is: FDA-approved (Ozempic, Rybelsus for T2D; Wegovy injection, Wegovy pill approved Dec 2025, and Wegovy HD 7.2 mg approved Mar 2026 for weight management). Evidence level: Strong.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Semaglutide live on its compound profile.
Semaglutide profileThis page is general information about the regulatory status of Semaglutide in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.